Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Bielli & Klauder
- Tarter Krinsky
- Teitelbaum Law Group
- Hagens Berman
- Simmons Hanly
- Debevoise & Plimpton
- Godfrey & Kahn
- Motley Rice
- Himes Petrarca
- Wachtell Lipton
- Hurwitz Fine
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- FBT Gibbons
- Pashman Stein
- Goodwin Procter
- Doster Ullom
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- ArentFox Schiff
- Dentons
- Faegre Drinker
- Duane Morris
- Foley & Lardner
- Jones Day
- Davis Polk
- Porter Hedges
- Willkie Farr
- Bentley & Bruning
- ASK LLP
- Hogan Lovells
- Joseph Hage
- Marino Tortorella
- White & Case
- UB Greensfelder
- HSF Kramer
- Seyfarth Shaw
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Blank Rome
- Kirkland & Ellis
- Cronin Fried
- Loeb & Loeb
- Phillips Lytle
- Slevin & Hart
- Doshi Legal Group
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Saul Ewing
- Lerner Arnold
- Taft Stettinius
- Arnold & Porter
- Troutman
- Burke Warren
- Wilk Auslander
- Stutzman Bromberg
- Shook Hardy
- Sherrard Roe
- Consovoy McCarthy
- Cleary Gottlieb
- Napoli Shkolnik
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- Potter Anderson
- Stevens & Lee
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Pillsbury Winthrop
- Robins Kaplan
- WilmerHale
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Levenfeld Pearlstein
- Rothstein Mandell
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Johnson & Johnson
- FTI Consulting Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- KVK Tech Inc.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- The Cigna Group
- Viatris Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- AlixPartners LLP
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- U.S. District Court for the District of Columbia
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
December 17, 2019
Sacklers Withdrew $10B From Purdue, Bankruptcy Probe Says
The Sackler family, owners of OxyContin maker Purdue Pharma LP, withdrew $10.4 billion from the company since 2008 as the company faced rising scrutiny over its role in the opioid crisis, according to a report filed Monday in New York bankruptcy court.
-
December 10, 2019
States Demand Purdue Fight Opioid Crisis With 9-Point Plan
Two dozen states opposed to Purdue Pharma's opioid crisis settlement are asking the bankrupt OxyContin maker to take nine actions to reduce the number of overdose deaths nationwide, saying that in the first half of 2019 alone in Massachusetts, more than two patients prescribed the drug died from overdoses each week.
-
December 09, 2019
High Court Won't Hear Arizona's Opioid Suit Against Sacklers
The U.S. Supreme Court on Monday declined to hear Arizona's unusual proposed complaint aimed at forcing the Sackler family, the owners of bankrupt OxyContin seller Purdue Pharma LP, to pay back billions of dollars they allegedly raided from the company.
-
December 04, 2019
Judge Holds Decision On Purdue Pharma CEO Bonus
A New York bankruptcy judge Wednesday said he would approve nearly $46 million in bonus payments for employees of Purdue Pharma, but held off considering a $1.3 million bonus for the company's CEO after hearing last-minute evidence of a $6 million payment made to him last year.
-
November 19, 2019
Purdue Gets OK To Pay States' Costs In Opioid-Related Ch. 11
A New York bankruptcy judge on Tuesday gave Purdue Pharma permission to pay the expenses of state governments participating in a settlement of claims related to Purdue's role in the opioid epidemic.
-
November 18, 2019
Purdue Opioid Claims Need National Fix, High Court Told
The U.S. Supreme Court has the authority to hear Arizona's unusual proposed complaint aimed at forcing the owners of bankrupt OxyContin seller Purdue Pharma LP to pay back billions of dollars they allegedly raided from the company, the state said Monday.
-
November 18, 2019
US Trustee Says Sackler Ties Bar E&Y From Purdue Ch. 11
Ernst & Young LLP shouldn't be allowed to serve as bankrupt Purdue Pharma LP's auditor because of the accounting firm's ongoing work for the Sackler family — which is expected to pay billions of dollars toward a massive settlement over Purdue's opioid marketing practices — the federal bankruptcy watchdog is arguing.
-
November 15, 2019
Purdue Says Paying States' Costs Will Help Ch. 11 Estate
Bankrupt drugmaker Purdue Pharma LP told a New York bankruptcy court Friday that its plan to pay the expenses of state governments participating in a settlement of claims related to Purdue's role in the opioid epidemic is a sound exercise of its business judgment and is essential to the Chapter 11 case.
-
November 14, 2019
Purdue's Law Firms Must Return Retainers, US Trustee Says
The U.S. trustee in Purdue Pharma LP's bankruptcy case has objected to the company's bid to let its law firms, including Skadden and Davis Polk, keep the retainers they were paid before Purdue's bankruptcy filing, saying the move unfairly favors those firms over other creditors in the case.
-
November 13, 2019
Purdue Claimants Oppose Payment Of Settling States' Costs
Unsecured creditors and individual claimants in the Purdue Pharma Chapter 11 are asking a New York bankruptcy judge to deny the company permission to pay the legal bills of a group of states that reached a tentative deal with the drugmaker.